Drugs / LIPO-4
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00121121 | Jul 2004 → Dec 2005 | HIV infectious disease | French National Agency for Research on AIDS and Viral Hepatitis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LIPO-4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00121121 ↗ |
| Modality | Vaccine | “HIV-lipopeptide candidate vaccine (LIPO-4)” PMID 17712402 ↗ Aug 2007 |
| Route | Other | “intradermally (0.1 ml, 100 microg of each peptide)” PMID 17712402 ↗ Aug 2007 |